American Association for the Study of Liver Diseases (AASLD) President's Press Conference, Nov. 1, 2008 in San Francisco
Posted on: Tuesday, 14 October 2008, 15:00 CDT
SAN FRANCISCO, Oct. 14 /PRNewswire/ -- AASLD President Arthur J. McCullough, MD, will host a press conference on the first full day of presentations at the Liver Meeting(R), the annual meeting of the American Association for the Study of Liver Diseases.
Dr. McCullough will highlight individual studies and themes from the almost 1600 abstracts to be presented at this year's meeting from the leading researchers in the field. Topics will include pilot studies and clinical trials for hepatitis and the latest findings in fatty liver disease, as well as important research in the areas of hepatocellular carcinoma and controversial issues in liver transplantation. He has selected to review 20 abstracts in advance of their actual presentation in scientific sessions for the benefit of the media.
Dr. McCullough is a professor of medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University and chairman of the Department of Gastroenterology and Hepatology at the Cleveland Clinic in Cleveland, Ohio. He is also the vice chair for Research for the Division of Medicine. His research interests include the study of non-alcoholic steatohepatitis and alcoholic steatohepatitis. The major research interests of his laboratory include the study of the normal response of protein and energy metabolism during feeding and how the presence of cirrhosis affects that response. Other areas of research include the further delineation of the causes of abnormal energy and protein metabolism in cirrhosis, while evaluating new nutritional and pharmacologic strategies in vivo to correct malnutrition in chronic liver disease.
AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting(R), held in San Francisco, California, October 31 - November 4, will bring together more than 7,000 researchers from 55 countries.
Press releases and all abstracts are available online at http://www.aasld.org/.
This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.xpresspress.com/
American Association for the Study of Liver Diseases
CONTACT: Gregory Bologna, +1-703-299-9766; or Ann Tracy, +1-703-299-9766,both of American Association for the Study of Liver Diseases
Web site: http://www.aasld.org/
Source: PRNewswire
Related Articles
- InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
- New Study Building Off Viral Genetics' Research Aims to Unlock the Mysteries Behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS
- Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
- MedImmune Presents Data Highlighting Its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
- Progen Presents Additional Analysis of Data From PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
- Accera, Inc. To Present Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
- Sunesis Presents Results From Phase I Clinical and Preclinical Studies of SNS-595 at American Association for Cancer Research Meeting
- Metabasis to Present at the Annual Meeting of the American Association for Cancer Research on Liver Targeting of Antiviral and Anticancer Drugs
- New Eloxatin(R) and Taxotere(R) Research to Be Presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
- Study Finds Autoimmune Diseases in Vets
 |
 |
User Comments (0)
RSS Feeds